Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer
Julie E. Bauman(George Washington University), Jennifer R. Grandis(University of California, San Francisco), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Antonio Jimeno(University of Colorado Cancer Center), Tanya J. Rath(University of Pittsburgh), William E. Gooding(UPMC Hillman Cancer Center), Faye M. Johnson(The University of Texas MD Anderson Cancer Center), Jason Kass(Brigham and Women's Hospital), Umamaheswar Duvvuri(City University of New York), John T. Flaherty(Johns Hopkins University), Malabika Sen(University of Pittsburgh Medical Center), Neil D. Gross(The University of Texas MD Anderson Cancer Center), John I. Song, Simion I. Chiosea(University of Pittsburgh), Robert L. Ferris(University of Pittsburgh), Lin Wang(Zhuzhou Central Hospital), Seungwon Kim(UPMC Hillman Cancer Center), Fred R. Hirsch(Tisch Hospital), Wendell G. Yarbrough(University of North Carolina at Chapel Hill), Kimberly Ellison(University of Colorado Denver), Jonas T. Johnson(University of Pittsburgh)
Cited by 55
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k